IGF-1 LR3 – 1 x 1mg – PRIME PHARMA

$130

Ideal peptide in the context of muscle development, Prime Pharma’s IGF-1 – LR3 peptide belongs to the family of peptides with a structure identical to that of insulin. It is a strongly anabolic hormone that is released in the liver as well as in peripheral tissues in response to GH so that new muscle fibers are built.

SKU: IGF-1 LR3 - 1 vial 1mg - Prime Pharma Categories: ,
Brands: Prime Pharma
Description

Description

  • Product and Laboratory: IGF 1 LR3 by Prime Pharma
  • Form: Subcutaneous injection
  • Ingredients: IGF-1 LR 3 (Insulin-Like Growth Factor-I LR3)
  • Concentration: 1 mg
  • Dosage: 100 mcg once daily (at bedtime)
Beginners Intermediate Advanced Female
100 mcg/day 100 mcg/day 100 mcg/day 100 mcg/day
  • Type: Weight loss cycle: reducing body fat (abdominal fat) and increasing lean mass
  • Protection: No need for protections
  • Level: All users
Brands

Brands

Prime Pharma

Shipped from WH Prime and Received in 4 to 5 days for $25 (click for details)
  • Our warehouse Prime Pharma is shipping only in Europe. But this warehouse is NOT shipping in Switzerland, UK, Norway, Sweden, Finland, Denmark.
  • Brands available from our Warehouse Prime Pharma : Prime Pharma
  • Shipping cost for our Warehouse Prime Pharma = $25 (+5% of total order amount if you select our insurance)
  • It takes usually 48 – 72 hours (except weekend) after your order is paid to ship.
  • After shipped, delivery in 4 – 5 days for France, and 1 to 2 days in Belgium and the Netherlands.
  • Shipping tracking number is sent 1 – 2 days after shipped.
  • We give particular attention to the packaging and delivery of all your products. Each shipment is treated with the utmost care. Our products are vacuum sealed to ensure protection, sterility, and especially incomparable discretion. We ship the products with their original packaging and instructions.
Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “IGF-1 LR3 – 1 x 1mg – PRIME PHARMA”

Your email address will not be published. Required fields are marked *